Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Dysplasia 1Squamous Intraepithelial Lesions 1Papillomavirus Infections 1Atypical Squamous Cells of the Cervix 1

Interventions

Restraint, Physical 2Human Papillomavirus DNA Tests 2Colposcopy 2epigallocatechin gallate 1Zinc Sulfate 1Vaginal Smears 1Papanicolaou Test 1Mindfulness-Based Stress Reduction 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1High-Throughput Screening Assays 1Gelatin 1Folic Acid 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Atypical Squamous Cells of the Cervix × epigallocatechin gallate × Gynecologic × Clear all
NCT07572396 2026-05-14

Phase II Study of Dysplasixâ„¢ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

Amplexd Therapeutics, Inc.

Phase 2 Recruiting
45 enrolled
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

Data powered by HemOnc (CC BY 4.0) Colophon âš¡